Artelo Biosciences, Inc. (ARTL)
Market: NASD |
Currency: USD
Address: 505 Lomas Santa Fe
Artelo Biosciences, Inc., a clinical stage biopharmaceutical company, develops and commercializes therapeutics that target lipid-signaling pathways in the United States. It's product candidate pipeline includes ART27.13, a synthetic dual cannabinoid G protein-coupled receptor agonist, which is in Phase 1b/2a clinical trial for the treatment of anorexia associated with cancer; ART12.11, a synthetic cannabidiol cocrystal for the treatment anxiety, post-traumatic stress disorder, epilepsy, inflammatory bowel disease, and other potential indications; and ART26.12, a fatty acid binding protein 5 inhibitor for treating chemotherapy induced peripheral neuropathy, diabetic neuropathy, prostate cancer and breast cancer, pain, dermatologic conditions, and anxiety disorders. The company was formerly known as Reactive Medical, Inc. and changed its name to Artelo Biosciences, Inc. in April 2017. Artelo Biosciences, Inc. was incorporated in 2011 and is based in Solana Beach, California.
Show more
📈 Artelo Biosciences, Inc. Historical Chart
📊 Statistics
-
Analyst 1 Year Price Target:
$20.00
-
Upside/Downside from Analyst Target:
33.78%
-
Broker Call:
2
-
Dividend Minimum 3 Year Yield:
0.00%
-
EPS Growth Range (1Y):
0-10%
-
Net Income Growth Range (1Y):
<0%
-
Revenue Growth Range (1Y):
-
💰 Dividend History
Year |
Annual Yield (%) |
Total Amount |
Current Yield (%) |
Ex Date |
Pay Date |
Particulars |
2025 |
- |
$0.166667 |
- |
2025-06-13 |
- |
Stock split |
Total Amount for 2025: $0.166667 |
2022 |
- |
$0.066667 |
- |
2022-08-10 |
- |
Stock split |
Total Amount for 2022: $0.066667 |
📅 Earnings & EPS History for Artelo Biosciences, Inc.
Date | Reported EPS |
---|
2026-03-02 (estimated upcoming) | - |
2025-11-10 (estimated upcoming) | - |
2025-11-09 (estimated upcoming) | - |
2025-08-11 (estimated upcoming) | - |
2025-08-10 (estimated upcoming) | - |
2025-05-13 | -4.32 |
2025-05-12 | - |
2025-05-11 | - |
2025-03-23 | - |
2025-03-03 | -7.02 |
2024-11-12 | -0.35 |
2024-11-12 | -2.1 |
2024-08-13 | -4.5 |
2024-08-12 | -0.75 |
2024-05-13 | -4.68 |
2024-05-13 | -0.78 |
2024-05-12 | -0.78 |
2024-03-25 | -1.04 |
2024-03-24 | -1.04 |
2023-11-13 | -0.83 |
2023-11-12 | -0.83 |
2023-08-10 | -0.56 |
2023-08-09 | -0.56 |
2023-05-11 | -0.76 |
2023-05-10 | -0.76 |
2023-03-31 | -1.18 |
2023-03-30 | -1.18 |
2022-11-08 | -0.82 |
2022-11-07 | -0.82 |
2022-08-09 | -5.4 |
2022-08-08 | -0.9 |
2022-05-12 | -0.75 |
2022-05-11 | -0.75 |
2022-03-21 | - |
2022-03-20 | - |
2022-01-12 | -1.2 |
2022-01-11 | -1.2 |
2021-11-29 | -6.3 |
2021-11-28 | -1.05 |
2021-07-12 | -9 |
2021-07-11 | -0.75 |
2021-04-13 | -9.9 |
2021-04-12 | -0.45 |
2021-01-14 | -12.6 |
2021-01-13 | -2.1 |
2020-11-04 | -18 |
2020-11-03 | -3 |
2020-07-13 | -24.3 |
2020-07-12 | -4.05 |
2020-04-13 | -36 |
2020-04-12 | -6 |
2020-01-13 | - |
2019-11-25 | -27 |
2019-11-24 | -4.5 |
2019-07-15 | -15.3 |
2019-07-14 | -0.17 |
2019-06-25 | - |
2019-06-24 | - |
📰 Related News & Research
No related articles found for "artelo biosciences".